Drug Metabolism & Pharmacokinetics

Better predict pharmacokinetic (PK) and drug-drug interactions (DDIs) with DMPK/ADME studies and computational modeling on your compound, prior to clinical trials, to move quickly from discovery to development.

Contact Us

In Vivo Metabolism


  • Metabolite Identification (MetID)
  • Human AME
  • In Vitro / In Vivo Cross Species
  • Metabolic Stability
  • Radiolabeled ADME


New PK study slots are now available in Q4 2022.

Fast starts. While study schedule openings last.

Are you looking for definitive pharmacokinetic (PK) data to meet your year-end goals, so that you can be ready to move your candidates forward quickly in the new year? We’ve ramped up and have a number of new study slots available in our schedule for definitive PK study work that can start now through December 31, 2022. If you can take advantage of completing one or more PK studies yet this year, and are ready to move fast, contact your Labcorp representative or email today for more details.

Looking to get into the clinic quickly?

Consider the integration possibilities between your preclinical and clinical studies

As an integrated preclinical & clinical CRO, we can offer you connected insights between your nonclinical pharmacology work and your clinical pharmacology studies and clinical trials.

For example, some PBPK pharmacometrics have been accepted in lieu of clinical DDI studies. 

Let's start a conversation

Contact Us